The hazards of chasing subgroups in neutral stroke trials

BACKGROUND: The majority of randomised controlled trials in acute stroke and many for prevention are neutral, i.e. they failed to reach statistical significance. However, many of these will find apparent benefit in a component of a subgroup, findings which may be 'chased' in a follow-up tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Bath, Philip M. (Author) , Howard, George (Author) , Hacke, Werner (Author)
Format: Article (Journal)
Language:English
Published: 11 March 2025
In: Neurological research and practice
Year: 2025, Volume: 7, Pages: 1-16
ISSN:2524-3489
DOI:10.1186/s42466-025-00369-0
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s42466-025-00369-0
Get full text
Author Notes:Philip M. Bath, George Howard and Werner Hacke

MARC

LEADER 00000caa a2200000 c 4500
001 1925474348
003 DE-627
005 20251020110847.0
007 cr uuu---uuuuu
008 250513s2025 xx |||||o 00| ||eng c
024 7 |a 10.1186/s42466-025-00369-0  |2 doi 
035 |a (DE-627)1925474348 
035 |a (DE-599)KXP1925474348 
035 |a (OCoLC)1528045289 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bath, Philip M.  |e VerfasserIn  |0 (DE-588)1059304031  |0 (DE-627)798251263  |0 (DE-576)415300606  |4 aut 
245 1 4 |a The hazards of chasing subgroups in neutral stroke trials  |c Philip M. Bath, George Howard and Werner Hacke 
264 1 |c 11 March 2025 
300 |b Illustrationen 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.05.2025 
520 |a BACKGROUND: The majority of randomised controlled trials in acute stroke and many for prevention are neutral, i.e. they failed to reach statistical significance. However, many of these will find apparent benefit in a component of a subgroup, findings which may be 'chased' in a follow-up trial. The evidence to date is that these follow-on trials are very likely to be neutral. - FINDINGS: We discuss the issue of chasing subgroups in neutral trials and illustrate the challenges in five pairs of exemplar acute stroke trials. Problems in the exemplar trials include failing to define the subgroup in advance or even changing its definition, failing to show that both the interaction test and the primary outcome in the component were statistically significant, failing to publish additional information on the positive subgroup component, having too many subgroups, failing to make the follow-on trial large enough and failing to report the findings of the follow-on trial. - CONCLUSION: When chasing a positive component in a subgroup, it is vital that the subgroup: should be plausible biologically, defined a priori and have a significant interaction test. Further the number of subgroups should be limited and the component of interest should be statistically significant. Explanations should be given as to why the component is positive and other components of the subgroup are negative. Other outcomes should also show potential benefit. Unless this guidance is followed, it is highly likely that follow-on trials will be neutral as has occurred previously. 
650 4 |a Analysis 
650 4 |a Design 
650 4 |a Neutral 
650 4 |a Randomised controlled trial 
650 4 |a Subgroup 
700 1 |a Howard, George  |e VerfasserIn  |4 aut 
700 1 |a Hacke, Werner  |d 1948-  |e VerfasserIn  |0 (DE-588)12021699X  |0 (DE-627)080530346  |0 (DE-576)164358854  |4 aut 
773 0 8 |i Enthalten in  |t Neurological research and practice  |d [London] : BioMed Central, 2019  |g 7(2025), Artikel-ID 17, Seite 1-16  |h Online-Ressource  |w (DE-627)1038162947  |w (DE-600)2947493-0  |w (DE-576)512479968  |x 2524-3489  |7 nnas  |a The hazards of chasing subgroups in neutral stroke trials 
773 1 8 |g volume:7  |g year:2025  |g elocationid:17  |g pages:1-16  |g extent:16  |a The hazards of chasing subgroups in neutral stroke trials 
856 4 0 |u https://doi.org/10.1186/s42466-025-00369-0  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250513 
993 |a Article 
994 |a 2025 
998 |g 12021699X  |a Hacke, Werner  |m 12021699X:Hacke, Werner  |d 910000  |d 911100  |d 50000  |e 910000PH12021699X  |e 911100PH12021699X  |e 50000PH12021699X  |k 0/910000/  |k 1/910000/911100/  |k 0/50000/  |p 3  |y j 
999 |a KXP-PPN1925474348  |e 4723850996 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"The hazards of chasing subgroups in neutral stroke trials","title_sort":"hazards of chasing subgroups in neutral stroke trials"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"name":{"displayForm":["Philip M. Bath, George Howard and Werner Hacke"]},"relHost":[{"id":{"issn":["2524-3489"],"zdb":["2947493-0"],"eki":["1038162947"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"[2019]-","publisher":"BioMed Central","publisherPlace":"[London]"}],"disp":"The hazards of chasing subgroups in neutral stroke trialsNeurological research and practice","corporate":[{"display":"Deutsche Gesellschaft für Neurologie","role":"isb"}],"recId":"1038162947","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"extent":"16","text":"7(2025), Artikel-ID 17, Seite 1-16","volume":"7","pages":"1-16","year":"2025"},"title":[{"title_sort":"Neurological research and practice","title":"Neurological research and practice","subtitle":"official journal of the German Neurological Society"}],"pubHistory":["Volume 1, issue 1 (December 2019)-"],"note":["Gesehen am 25. März 2019"]}],"note":["Gesehen am 13.05.2025"],"origin":[{"dateIssuedDisp":"11 March 2025","dateIssuedKey":"2025"}],"person":[{"family":"Bath","given":"Philip M.","display":"Bath, Philip M.","role":"aut"},{"display":"Howard, George","role":"aut","family":"Howard","given":"George"},{"family":"Hacke","given":"Werner","display":"Hacke, Werner","role":"aut"}],"physDesc":[{"noteIll":"Illustrationen","extent":"16 S."}],"id":{"doi":["10.1186/s42466-025-00369-0"],"eki":["1925474348"]},"recId":"1925474348"} 
SRT |a BATHPHILIPHAZARDSOFC1120